| Literature DB >> 29536307 |
A I Autenshlyus1,2, I I Brusentsov3,4, I O Marinkin3, S A Smirnova5, M Yu Rukavishnikov5, V V Lyakhovich6.
Abstract
The content of mRNA of the histidine-rich glycoprotein (HRG), a potential marker of malignant neoplasia, which can be used in differential diagnosis of breast tumors, was determined in 110 breast tumor biopsy samples. The presence of HRG mRNA did not depend on the cancer type, on the preoperative treatment or its absence, as well as on the tumor progression stage and the presence of metastases.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29536307 DOI: 10.1134/S1607672918010106
Source DB: PubMed Journal: Dokl Biochem Biophys ISSN: 1607-6729 Impact factor: 0.788